The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review

Objective Escitalopram (ESC) is considered one of the most effective selective serotonin reuptake inhibitors for the treatment of major depression. However, little is known on its potential risk of inducing major malformations (MMs) and perinatal complications (PCs). Hence, aim of the present study...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human psychopharmacology 2012-11, Vol.27 (6), p.534-539
Hauptverfasser:	Bellantuono, Cesario, Bozzi, Francesca, Orsolini, Laura, Catena-Dell'Osso, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Drug-Induced - etiology Antidepressive Agents, Second-Generation - adverse effects Breast Feeding - adverse effects breastfeeding Citalopram - adverse effects escitalopram Evidence-Based Medicine Female Humans Infant, Newborn Lactation major malformations Male Maternal-Fetal Exchange perinatal complications Pregnancy selective serotonin reuptake inhibitors (SSRIs) Serotonin Uptake Inhibitors - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!